We are live on ! Find out more
DS

David Shaw D.E. Shaw & Co

AUM $210B
1-Year Est. Return 57.28%
 

David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.

This Fund
S&P 500
This Quarter Est. Return
+7.83%
1 Year Est. Return
+57.28%
3 Year Est. Return
+174.65%
5 Year Est. Return
+213.13%
10 Year Est. Return
+910.08%
AUM
$104B
AUM Growth
-$8.26B
Cap. Flow
-$18.3B
Cap. Flow %
-17.65%
Top 10 Hldgs %
9.93%
Holding
4,712
New
825
Increased
1,119
Reduced
1,773
Closed
730

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$862M
2
BIDU icon
Baidu
BIDU
+$752M
3
TME icon
Tencent Music
TME
+$426M
4
KO icon
Coca-Cola
KO
+$424M
5
NVDA icon
NVIDIA
NVDA
+$383M

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$981M
2
WFC icon
Wells Fargo
WFC
+$673M
3
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$574M
4
MRNA icon
Moderna
MRNA
+$442M
5
DD icon
DuPont de Nemours
DD
+$415M

Sector Composition

Rank Sector Weight
1 Technology 16.45%
2 Consumer Discretionary 10.49%
3 Communication Services 9.04%
4 Healthcare 8.89%
5 Financials 6.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CFB
4426
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
-10,392
Closed -$112K
ZUO
4427
DELISTED
Zuora, Inc.
ZUO
-98,716
Closed -$1.38M
RVNC
4428
DELISTED
Revance Therapeutics, Inc.
RVNC
-8,933
Closed -$253K
AKTS
4429
DELISTED
Akoustis Technologies Inc
AKTS
-44,472
Closed -$544K
SAVE
4430
DELISTED
Spirit Airlines, Inc.
SAVE
-535,877
Closed -$17.2M
ME
4431
DELISTED
23andMe Holding Co
ME
-15,044
Closed -$3.44M
GTHX
4432
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
-17,465
Closed -$314K
BIG
4433
PUT
DELISTED
Big Lots, Inc.
BIG
-20,000
Closed -$859K
CONN
4434
PUT
DELISTED
Conn's Inc.
CONN
-297,000
Closed -$3.47M
EVBG
4435
PUT
DELISTED
Everbridge, Inc. Common Stock
EVBG
-50,000
Closed -$7.45M
DCPH
4436
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
-16,943
Closed -$789K
AWH
4437
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
-1,993
Closed -$201K
CONXU
4438
DELISTED
CONX Corp. Unit
CONXU
-1,000,000
Closed -$10.4M
EIGR
4439
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
-777
Closed -$286K
GOEV
4440
DELISTED
Canoo Inc. Class A Common Stock
GOEV
-5,435
Closed -$34.5M
NVTA
4441
CALL
DELISTED
Invitae Corporation
NVTA
-67,500
Closed -$2.82M
CORR
4442
DELISTED
CorEnergy Infrastructure Trust, Inc.
CORR
-50,496
Closed -$346K
VMW
4443
PUT
DELISTED
VMware, Inc
VMW
-46,600
Closed -$6.54M
HCCI
4444
DELISTED
Heritage-Crystal Clean, Inc.
HCCI
-15,163
Closed -$319K
RAD
4445
DELISTED
Rite Aid Corporation
RAD
-547,821
Closed -$8.67M
CELL
4446
DELISTED
PhenomeX Inc. Common Stock
CELL
-14,677
Closed -$1.31M
DRTT
4447
DELISTED
DIRTT Environmental Solutions Ltd. Common Shares
DRTT
-10,900
Closed -$27K
ARNC
4448
CALL
DELISTED
Arconic Corporation
ARNC
-8,875
Closed -$264K
KDNY
4449
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
-35,736
Closed -$567K
AZRE
4450
DELISTED
Azure Power Global Limited
AZRE
-5,699
Closed -$232K

Similar funds

David Shaw's Q1 2021 Portfolio in Review

As of Q1 2021, David Shaw held 4,712 positions worth $104B, down 7.4% from $112B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.

David Shaw withdrew a net $18.3B in Q1 2021, closing 730 positions and reducing 1,773 holdings. Its most notable exit was AstraZeneca, an estimated $214M position sold in full.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Communication Services.

Against the trend, David Shaw opened a new position in Baidu worth $627M.

  • David Shaw's largest Q1 2021 buy was Baidu: 2,881,724 shares worth $627M.
  • David Shaw added most to Tesla in Q1 2021, an estimated $862M increase.
  • David Shaw's biggest Q1 2021 reduction was Amazon, cutting an estimated $981M.
  • David Shaw fully exited AstraZeneca in Q1 2021, selling an estimated $214M.
  • David Shaw's ten largest holdings make up 9.9% of its $104B portfolio in Q1 2021.
  • David Shaw opened 825 new positions and closed 730 in Q1 2021.
  • David Shaw's portfolio value fell 7.4% quarter-over-quarter to $104B.

Based on D.E. Shaw & Co's 13F filing for Q1 2021, filed 17 May 2021.